Antimicrobial Resistance (AMR) is a complex global health challenge, with significant implications for human health, social well-being, and economic development.
On 6 September 2022, WHO will hold a high-level webinar to launch and share the findings of the Global Evidence Review on Health and Migration (GEHM) with a focus on AMR. The report, the fourth of the GEHM series, explores evidence on access and use of essential antimicrobials in international migrant and refugee populations and provides policy considerations to support policymakers in addressing national and global challenges related to AMR and migration.
Launched on 17 June 2021, the GEHM series is an evidence-informed normative product to respond to policy questions on migration-related public health priorities. The GEHM series also addresses knowledge gaps and proposes policy considerations on the health status and health policies related to refugees and migrants by summarizing the best available evidence worldwide.
The upcoming GEHM on AMR is the result of the interdivisional collaboration between WHO’s Health and Migration Programme (PHM), the Department of Surveillance, Prevention and Control (SPC) of the Antimicrobial Resistance Division (AMR), and the Global Strategy Lab at York University – the WHO Collaborating Centre on Global Governance of Antimicrobial resistance. PHM and SPC/AMR departments partnered with WHO Regional Offices, the International Organization for Migration (IOM), the Office of the United Nations High Commissioner for Refugees (UNHCR), Médecins Sans Frontières (MSF), and ReAct to identify supplementary evidence, with an emphasis on identifying case studies and best practices for policy considerations and interventions.
The event is open to everyone but is particularly aimed at high level policymakers, including ministries of health, health sector managers, academic institutions, and other key stakeholders.
The event will take place on Tuesday 6 September 2022 from 14:00 to 15:00 CEST (timezone adjuster).
- Dr Hanan Balkhy, Assistant Director-General for Antimicrobial Resistance (AMR)
Chair – Rifat Hossain, Data and evidence, Health and Migration Programme (PHM)
Strategic importance of Global Evidence review on Health and Migration (GEHM) for policy making for refugees and migrants
- Dr Palmira Immordino, Data and evidence, PHM
Capturing the evidence on access to essential antibiotics in migrant and refugee populations
- Dr Susan Rogers Van Katwyk, Managing Director, WHO Collaborating Centre on Global Governance of Antimicrobial Resistance
Developing a “People-centred framework” for addressing Antimicrobial resistance (AMR)
- Mr Anand Balachandran, Unit Head, AMR, SPC – National Action Plans and Monitoring
- Facilitated by Dr Enrique Castro-Sánchez, Associate Professor in Infection Prevention and Improvement, College of Nursing, Midwifery and Healthcare, University of West London
- Dr Santino Severoni, Director, PHM, WHO
- Dr Catharina Van Weezenbeek, Director, SPC/AMR